my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Company Portrait
Calgary, Alberta-based SemBioSys is focused on leveraging its unique proprietary platform to manufacture high-value proteins and oils. SemBioSys’ seed-based protein production system can provide for its partners product enablement, exceptionally low cost and unprecedented scalability. SemBioSys is applying the platform with high selectivity to products with tremendous clinical promise and value potential. The Company’s current pharmaceutical development programs include insulin (SBS-1000, regulated as a biosimilar in Europe) and Apo AI Milano, a next-generation cardiovascular therapy. SemBioSys' proprietary safflower-derived Apo AIMilano is a des-1,2- variant of Apo AI Milano as previously described in the literature. SemBioSys is listed on the Toronto Stock Exchange under the ticker SBS.
Industrial Sectors
Contact / Request information
Contact the company and request further information free of charge:
Watchlist
This is where you can add this company to your personal favourites
SemBioSys announces senior management change
SemBioSys Genetics Inc. announced that effective March 25, 2010, Professor Maurice Moloney, Ph.D., the Company's Founder and Chief Scientific Officer has accepted a full-time position with the Biotechnology and Biological Sciences Research Council (BBSRC) and the Lawes Trust in the United K ... more
SemBioSys begins phase I/II trial of insulin produced in plant seeds
SemBioSys Genetics Inc. announced that it has initiated a phase I/II clinical trial of its plant-produced insulin with the first injection of its drug in humans. The trial, taking place in the United Kingdom (UK), will include up to 30 healthy volunteers in a three-arm study (SBS-1000 insul ... more
SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
SemBioSys Genetics Inc. announced that it has been granted European patent EP0986309(B1) entitled "Uses of Oil Bodies". The patent has been issued to SemBioSys, which has exclusively licensed commercial rights associated with the patent to Botaneco Specialty Ingredients Inc., its wholly own ... more
Calgary, Alberta-based SemBioSys is focused on leveraging its unique proprietary platform to manufacture high-value proteins and oils. SemBioSys’ seed-based protein production system can provide for its partners product enablement, exceptionally low cost and unprecedented scalability. SemBi ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
